HomeFileStructural heart disease

Structural heart disease

View Category

Mitral valve

TCT 2023 | EXPAND G4

The EXPAND G4 is a prospective multicenter single arm study on real life patients.  It included a total...
solaci -
Learn More
Structural Heart Disease

TCT 2023 | ALIGN AR Trial

Dr. Thourani has presented the ALIGN AR, a single arm, multicenter and non-blinded trial on the use...
solaci -
Learn More
Structural Heart Disease

TCT 2023 | EVOLUT Low Risk: 4-Year Follow-up

In recent years, there has been a steady increase in the use of transcatheter aortic valve replacement...
solaci -
Learn More
Left Atrial Apendix Closure

TCT 2023 | SWISS-APERO: One-Year Events After Left Atrial Appendage Closure with Amulet or Watchman FLX Device

It has been observed that the persistence of an opening in the left atrial appendage after percutaneous...
solaci -
Learn More
Structural heart disease

TCT 2023 | The WATCH-TAVR Study

In the TVT registry, around 40% of the patients eligible for transcatheter aortic valve replacement (TAVR) had...
solaci -
Learn More
Pulmonary Valve

FLAME Study: FlowTriever Device in High-Risk Pulmonary Embolism

High-risk pulmonary embolism (HR-PE) is characterized by hemodynamic instability and marked deformation of the right ventricular (RV)...
solaci -
Learn More
Other

OBSERVANT II: Post TAVR 30-Day and 6-Month Stroke Predictors

Despite stroke rate has declined since the early days of transcatheter aortic valve replacement (TAVR), it remains...
solaci -
Learn More
Structural heart disease

Cause of Cardiac Death after TAVR at Present

Cardiac failure (CF) and sudden cardiac death (SCD) stand out as two of the main causes of...
solaci -
Learn More